Free skin cancer mobile app

Article

The University of Michigan Health System developed a free mobile app for iPhone and iPad users to track skin changes and monitor for signs of skin cancer. UMSkinCheck lets users create a photographic baseline of skin lesions and then reminds users to check the lesion for changes over time. If a mole or lesion changes, the user can share the photo with a dermatologist to determine next steps. The app also takes you step by step through a self-exam and will calculate your risk of developing melanoma. It also has examples of common skin lesions and takes you through the ABCDs (asymmetry, border, color, difference) of melanoma. Users can get sun safety and sunscreen tips as well. Download the UMSkinCheck app on iTunes.

Related Videos
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content
Meaghan Mooney, B.S.N, RN, OCN won the 2024 Extraordinary Healer Award. From left: Kristie L. Kahl, Meredith Cooper, Meaghan Mooney, B.S.N, RN, OCN, Kristen Dahlgren

Meaghan Mooney, B.S.N., RN, OCN, Wins CURE’s 2024 Extraordinary Healer® Award

April 25th 2024
Article

During this in-person event, over 500 attendees celebrated the remarkable efforts made by oncology nurses in the care of patients with cancer.

Read More

cancer horizons logo: a white microphone on a navy blue background

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

March 11th 2024
Podcast

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Listen

Illustration of a woman with long light brown hair and light brown eyes.

Receiving Chemotherapy for Colon Cancer on My Birthday

April 24th 2024
Article

At first, I wanted to avoid receiving chemotherapy at all costs, but I realized taking it would be the beginning of staying cancer-free.

Read More

cancer horizons podcast logo: a white microphone on a blue background

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

March 4th 2024
Podcast

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

Listen

Image of FDA approval, what you need to know.

Enhertu Marks First Therapy Approved Across HER2-Positive Solid Tumors

April 24th 2024
Article

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.

Read More

Image of tumors located in the right lung.

Tecentriq, Cabometyx May Not Improve Survival Over Chemo in NSCLC

April 23rd 2024
Article

Tecentriq plus Cabometyx conferred no overall survival benefit when compared with chemotherapy, a study showed.

Read More